Funder: National Institutes of Health
Due Dates: May 25, 2025 (Renewal/Resubmission/Revision)
Funding Amounts: Up to $220,000 direct costs per year; maximum project period 3 years; cooperative agreement (U24)
Summary: Funds expert panels to select and determine the clinical significance of genes and genomic variants for high-priority diseases using standardized NIH procedures and tools.
Key Information: Clinical trials are not allowed; limited submission—see eligibility and application details.